These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13635024)

  • 1. Depression of norepinephrine and 5-hydroxytryptamine in the brain by benzoquinolizine derivatives.
    PLETSCHER A; BESENDORF H; GEY KF
    Science; 1959 Mar; 129(3352):844. PubMed ID: 13635024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of noradrenaline and 5-hydroxy-tryptamine in the central action of Rauwolfia alkaloids and benzoquinolizine derivatives.
    PAASONEN MK
    Biochem Pharmacol; 1961 Feb; 5():389-91. PubMed ID: 13731870
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective depletion of noradrenaline and 5-hydroxytryptamine from rat brain and intestine by Rauwolfia alkaloids.
    KARKI NT; PAASONEN MK
    J Neurochem; 1959 Feb; 3(4):352-7. PubMed ID: 13642070
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological distribution of a benzoquinolizine derivative and its effect on the 5-hydroxytryptamine and noradrenalin content of the tissue].
    SCHWARTZ DE; PLETSCHER A; GEY KF; RIEDER J
    Helv Physiol Pharmacol Acta; 1960; 18():10-6. PubMed ID: 14443975
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of benzquinamide on avoidance behavior and brain amine levels.
    WEISSMAN A; FINGER KF
    Biochem Pharmacol; 1962 Sep; 11():871-80. PubMed ID: 14005923
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism between harmaline and longacting monoamine oxidase inhibitors concerning the effect on 5-hydroxytryptamine and norepinephrine metabolism in the brain.
    PLETSCHER A; BESENDORF H
    Experientia; 1959 Jan; 15(1):25-6. PubMed ID: 13619675
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of different heterocyclics on the incorporation of 5-hydroxytryptamine and noradrenaline in a rat brain preparation].
    Uzan A; Le Fur G
    Ann Pharm Fr; 1975; 33(6-7):345-54. PubMed ID: 1220603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benzo[a]quinolizine, a new type of compounds, with effects on the cerebral metabolism of 5-hydroxytryptamine and noradrenalin].
    PLETSCHER A; BESENDORF H; BACHTOLD HP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 232(3):499-506. PubMed ID: 13552728
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of raunescine and isoraunescine on behaviour and on the 5-hydroxytryptamine and noradrenaline contents of brain.
    PAASONEN MK; DEWS PB
    Br J Pharmacol Chemother; 1958 Mar; 13(1):84-8. PubMed ID: 13523140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of 5-hydroxytryptamine in the rat brain by raunescine.
    PAASONEN MK; KARKI NT
    Br J Pharmacol Chemother; 1959 Jun; 14(2):164-7. PubMed ID: 13662567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of 5-hydroxytryptamine by benzoquinolizine derivatives with sedative action.
    PLETSCHER A
    Science; 1957 Sep; 126(3272):507. PubMed ID: 13467235
    [No Abstract]   [Full Text] [Related]  

  • 12. [EXPERIMENTAL AND CLINICAL PHARMACOLOGY OF ALKALOIDS AND DERIVATIVES OF RAUWOLFIA AND OF BENZOQUINOLIZINE DERIVATIVES WITH PARTICULAR REFERENCE TO THEIR CARDIOVASCULAR EFFECTS].
    MARINO A
    Clin Ter; 1964 Nov; 31():230-77. PubMed ID: 14235389
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible interrelationship between release of brain norepinephrine and serotonin by reserpine.
    BRODIE BB; OLIN JS; KUNTZMAN RG; SHORE PA
    Science; 1957 Jun; 125(3261):1293-4. PubMed ID: 13432798
    [No Abstract]   [Full Text] [Related]  

  • 14. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of chlorpromazine and chlorprothixene on the cerebral metabolism of 5-hydroxytryptamine, norepinephrine and dopamine.
    GEY KF; PLETSCHER A
    J Pharmacol Exp Ther; 1961 Jul; 133():18-24. PubMed ID: 13704858
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of delta9-tetrahydrocannabinol on the metabolism of 3H-5-hydroxytryptamine and 3H-norepinephrine in the rat brain.
    Ho BT; Taylor D; Englert LF
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):645-50. PubMed ID: 4828760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuropharmacological approach to major depression].
    Nakazawa K
    Yakubutsu Seishin Kodo; 1991 Apr; 11(2):171-6. PubMed ID: 1656650
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of biological psychiatric depression research (author's transl)].
    Matussek N
    MMW Munch Med Wochenschr; 1981 May; 123(19):793-4. PubMed ID: 6262640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression of serotonin and norepinephrine levels in brain stem of rabbit by ethanol.
    GURSEY D; OLSON RE
    Proc Soc Exp Biol Med; 1960 Jun; 104():280-1. PubMed ID: 13830375
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of alpha-alkylated tryptamine derivatives on 5-hydroxytryptamine metabolism in vivo.
    GEY KF; PLETSCHER A
    Br J Pharmacol Chemother; 1962 Aug; 19(1):161-7. PubMed ID: 13898151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.